IGG, IGM, AND IGA RESPONSE TO HIV IN INFANTS BORN TO HIV-1-INFECTED MOTHERS

被引:0
作者
SCHUPBACH, J
TOMASIK, Z
JENDIS, J
BONI, J
SEGER, R
KIND, C
机构
[1] UNIV ZURICH,CHILDRENS HOSP,ZURICH,SWITZERLAND
[2] KANTONSSPITAL,DIV NEONATOL,ST GALLEN,SWITZERLAND
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1994年 / 7卷 / 05期
关键词
HIV-1; PEDIATRIC INFECTION; PERINATAL INFECTION; IMMUNOGLOBULINS; IGG; IGA; IGM; SEROCONVERSION; WESTERN BLOT;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Children born to HIV-l-positive mothers were prospectively tested for HIV-reactive IgG, IgM, and IgA by Western blot, in order to study the children's humoral immune response in the background of passively transferred maternal IgG. In infected infants, a response was first seen at 1-3 months for env-reactive IgM and IgA, as well as gag-reactive IgM and IgG. This was followed by production of IgG to env, IgA to pol and to gag p17 and p55 at 7-9 months, and IgG to pol at 10-12 months. IgG Western blot positivity by all interpretation guidelines in all infected infants was found by 10-12 months. Subsequently, only IgG to env and p24, and IgA to env were maintained in ail, whereas IgG to pol and p17 disappeared again in a significant fraction. A considerable proportion of uninfected infants also produced gag-reactive antibodies: IgM at 1-3 months, followed by IgG, which persisted in 10-20% and were also found in children born to uninfected mothers. These antibodies were, however, present at lower titers than in infected infants and were apparently produced in response to agent(s) different from HIV. Maternal antibodies to env disappeared significantly faster in infected than uninfected infants. Traces of HIV-reactive IgG were present for up to 21 months in children who subsequently seroreverted completely.
引用
收藏
页码:421 / 427
页数:7
相关论文
共 50 条
  • [21] Molecular analysis of HIV-1 gp120 antibody response using isotype IgM and IgG phage display libraries from a long-term non-progressor HIV-1-infected individual
    Torán, JL
    Kremer, L
    Sánchez-Pulido, L
    de Alborán, IM
    del Real, G
    Llorente, M
    Valencia, A
    de Mon, MA
    Martínez-A, C
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (09) : 2666 - 2675
  • [22] HIV-2-INFECTED PATIENTS SURVIVE LONGER THAN HIV-1-INFECTED PATIENTS
    WHITTLE, H
    MORRIS, J
    TODD, J
    CORRAH, T
    SABALLY, S
    BANGALI, J
    NGOM, PT
    ROLFE, M
    WILKINS, A
    AIDS, 1994, 8 (11) : 1617 - 1620
  • [23] Selective transduction of HIV-1-infected cells by the combination of HIV and MMLV vectors
    Sakai, N
    Miyake, K
    Suzuki, N
    Shimada, T
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 73 (04) : 476 - 482
  • [24] In men at risk of HIV infection, IgM, IgG1, IgG3, and IgA reach the human foreskin epidermis
    Lemos, M. P.
    Karuna, S. T.
    Mize, G. J.
    Fong, Y.
    Montano, S. M.
    Ganoza, C.
    Lama, J. R.
    Sanchez, J.
    McElrath, M. J.
    MUCOSAL IMMUNOLOGY, 2016, 9 (03) : 798 - 808
  • [25] PLASMA VIREMIA IN SERONEGATIVE HIV-1-INFECTED INDIVIDUALS
    ENSOLI, F
    FIORELLI, V
    MEZZAROMA, I
    DOFFIZI, G
    RAINALDI, L
    LUZI, G
    FIORILLI, M
    AIUTI, F
    AIDS, 1991, 5 (10) : 1195 - 1199
  • [26] EARLY IMPAIRMENT OF GUT MUCOSAL IMMUNITY IN HIV-1-INFECTED CHILDREN
    QUESNEL, A
    MOJA, P
    BLANCHE, S
    GRISCELLI, C
    GENIN, C
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 97 (03) : 380 - 385
  • [27] Thiol-Selective Mechanism of HIV Antigen Conjugation with Serum IgM, IgG, and IgA
    V. V. Kostyushov
    Bulletin of Experimental Biology and Medicine, 2000, 130 : 1147 - 1149
  • [28] Micronutrient profiles in HIV-1-Infected heterosexual adults
    Skurnick, JH
    Bogden, JD
    Baker, H
    Kemp, FW
    Sheffet, A
    Quattrone, G
    Louria, DB
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1996, 12 (01) : 75 - 83
  • [29] PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN HIV-1-INFECTED CHILDREN
    BERGER, JR
    SCOTT, G
    ALBRECHT, J
    BELMAN, AL
    TORNATORE, C
    MAJOR, EO
    AIDS, 1992, 6 (08) : 837 - 841
  • [30] Myelopathy in a previously asymptomatic HIV-1-infected patient
    Eyer-Silva, WA
    Auto, I
    Pinto, JFC
    Morais-de-Sá, CA
    INFECTION, 2001, 29 (02) : 99 - 102